Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Oral Anticoagulation and Risk of Symptomatic Hemorrhagic Transformation in Stroke Patients Treated With Mechanical Thrombectomy: Data From the Nordictus Registry

  • Ramos-Araque, M.E.
  • Chavarría-Miranda, A.
  • Gómez-Vicente, B.
  • López-Cancio Martínez, E.
  • Castañón Apilánez, M.
  • Castellanos, M.
  • López Fernández, M.
  • Tejada Meza, H.
  • Marta Moreno, J.
  • Tejada García, J.
  • Beltrán Rodríguez, I.
  • de la Riva, P.
  • Díez, N.
  • Arias Rivas, S.
  • Santamaría Cadavid, M.
  • Bravo Anguiano, Y.
  • Bártulos Iglesias, M.
  • Palacio Portilla, E.J.
  • Revilla García, M.
  • Timiraos Fernández, J.J.
  • Arenaza Basterrechea, N.
  • Maciñeiras Montero, J.L.
  • Vicente Alba, P.
  • Julián Villaverde, F.J.
  • Pinedo Brochado, A.
  • Azkune, I.
  • Mar, F.M.
  • Luna, A.
  • Arenillas, J.F.
Introduction: We aimed to evaluate if prior oral anticoagulation (OAC) and its type determines a greater risk of symptomatic hemorrhagic transformation in patients with acute ischemic stroke (AIS) subjected to mechanical thrombectomy. Materials and Methods: Consecutive patients with AIS included in the prospective reperfusion registry NORDICTUS, a network of tertiary stroke centers in Northern Spain, from January 2017 to December 2019 were included. Prior use of oral anticoagulants, baseline variables, and international normalized ratio (INR) on admission were recorded. Symptomatic intracranial hemorrhage (sICH) was the primary outcome measure. Secondary outcome was the relation between INR and sICH, and we evaluated mortality and functional outcome at 3 months by modified Rankin scale. We compared patients with and without previous OAC and also considered the type of oral anticoagulants. Results: About 1.455 AIS patients were included, of whom 274 (19%) were on OAC, 193 (70%) on vitamin K antagonists (VKA), and 81 (30%) on direct oral anticoagulants (DOACs). Anticoagulated patients were older and had more comorbidities. Eighty-one (5.6%) developed sICH, which was more frequent in the VKA group, but not in DOAC group. OAC with VKA emerged as a predictor of sICH in a multivariate regression model (OR, 1.89 [95% CI, 1.01–3.51], p = 0.04) and was not related to INR level on admission. Prior VKA use was not associated with worse outcome in the multivariate regression model nor with mortality at 3 months. Conclusions: OAC with VKA, but not with DOACs, was an independent predictor of sICH after mechanical thrombectomy. This excess risk was associated neither with INR value by the time thrombectomy was performed, nor with a worse functional outcome or mortality at 3 months.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Stroke etiologies in patients with COVID-19: the SVIN COVID-19 multinational registry

  • Ramos-Araque, María E.
  • Ribó Jacobi, Marc
  • López, Cristina
  • de Lera, Mercedes
  • Siegler, James
  • Requena, Manuel
Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Ictus; Mortalitat, Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Ictus; Mortalidad, Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Stroke; Mortality, Background and purpose Coronavirus disease 2019 (COVID-19) is associated with a small but clinically significant risk of stroke, the cause of which is frequently cryptogenic. In a large multinational cohort of consecutive COVID-19 patients with stroke, we evaluated clinical predictors of cryptogenic stroke, short-term functional outcomes and in-hospital mortality among patients according to stroke etiology. Methods We explored clinical characteristics and short-term outcomes of consecutively evaluated patients 18 years of age or older with acute ischemic stroke (AIS) and laboratory-confirmed COVID-19 from 31 hospitals in 4 countries (3/1/20–6/16/20). Results Of the 14.483 laboratory-confirmed patients with COVID-19, 156 (1.1%) were diagnosed with AIS. Sixty-one (39.4%) were female, 84 (67.2%) white, and 88 (61.5%) were between 60 and 79 years of age. The most frequently reported etiology of AIS was cryptogenic (55/129, 42.6%), which was associated with significantly higher white blood cell count, c-reactive protein, and D-dimer levels than non-cryptogenic AIS patients (p</=0.05 for all comparisons). In a multivariable backward stepwise regression model estimating the odds of in-hospital mortality, cryptogenic stroke mechanism was associated with a fivefold greater odds in-hospital mortality than strokes due to any other mechanism (adjusted OR 5.16, 95%CI 1.41–18.87, p = 0.01). In that model, older age (aOR 2.05 per decade, 95%CI 1.35–3.11, p < 0.01) and higher baseline NIHSS (aOR 1.12, 95%CI 1.02–1.21, p = 0.01) were also independently predictive of mortality. Conclusions Our findings suggest that cryptogenic stroke among COVID-19 patients carries a significant risk of early mortality., MER-A was funded by The Instituto de Salud Carlos III (JR19/00020), Spain.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Stroke etiologies in patients with COVID-19, the SVIN COVID-19 multinational registry

  • Ramos-Araque, María E.
  • Siegler, James E.|||0000-0003-0287-3967
  • Ribo, Marc|||0000-0001-9242-043X
  • Requena, Manuel|||0000-0002-5671-6484
  • López, Cristina
  • De Lera Alfonso, Mercedes|||0000-0002-3954-9071
  • Arenillas, Juan F.|||0000-0001-7464-6101
  • Hernández Pérez, Isabel
  • Gómez-Vicente, Beatriz
  • Talavera, Blanca
  • Cardona Portela, Pere|||0000-0002-5849-1258
  • Nuñez Guillen, Ana|||0000-0002-5059-5503
  • Urra, Xabier|||0000-0002-4763-5252
  • Llull, Laura
  • Renú, Arturo
  • Nguyen, Thanh N.|||0000-0002-2810-1685
  • Jillella, Dinesh|||0000-0002-5399-0170
  • Nahab, Fadi
  • Nogueira, Raul
  • Haussen, Diogo
  • Then, Ryna
  • Thon, Jesse M.
  • Esparragoza, Luis Rodríguez
  • Hernández-Pérez, María|||0000-0001-8279-7954
  • Bustamante, Alejandro|||0000-0003-4390-8900
  • Mansour, Ossama Yassin|||0000-0001-8814-6431
  • Megahed, Mohammed
  • Hassan, Tamer
  • Liebeskind, David S.|||0000-0002-5109-8736
  • Hassan, Ameer E.|||0000-0002-7148-7616
  • Bushnaq, Saif
  • Osman, Mohamed
  • Rodriguez Vazquez, Alejandro|||0000-0002-3448-9778
Coronavirus disease 2019 (COVID-19) is associated with a small but clinically significant risk of stroke, the cause of which is frequently cryptogenic. In a large multinational cohort of consecutive COVID-19 patients with stroke, we evaluated clinical predictors of cryptogenic stroke, short-term functional outcomes and in-hospital mortality among patients according to stroke etiology. We explored clinical characteristics and short-term outcomes of consecutively evaluated patients 18 years of age or older with acute ischemic stroke (AIS) and laboratory-confirmed COVID-19 from 31 hospitals in 4 countries (3/1/20-6/16/20). Of the 14.483 laboratory-confirmed patients with COVID-19, 156 (1.1%) were diagnosed with AIS. Sixty-one (39.4%) were female, 84 (67.2%) white, and 88 (61.5%) were between 60 and 79 years of age. The most frequently reported etiology of AIS was cryptogenic (55/129, 42.6%), which was associated with significantly higher white blood cell count, c-reactive protein, and D-dimer levels than non-cryptogenic AIS patients (p</=0.05 for all comparisons). In a multivariable backward stepwise regression model estimating the odds of in-hospital mortality, cryptogenic stroke mechanism was associated with a fivefold greater odds in-hospital mortality than strokes due to any other mechanism (adjusted OR 5.16, 95%CI 1.41-18.87, p = 0.01). In that model, older age (aOR 2.05 per decade, 95%CI 1.35-3.11, p < 0.01) and higher baseline NIHSS (aOR 1.12, 95%CI 1.02-1.21, p = 0.01) were also independently predictive of mortality. Our findings suggest that cryptogenic stroke among COVID-19 patients carries a significant risk of early mortality. The online version contains supplementary material available at 10.1186/s12883-021-02075-1.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Stroke etiologies in patients with COVID-19: the SVIN COVID-19 multinational registry

  • Ramos-Araque, María E.
  • Ribó Jacobi, Marc
  • López, Cristina
  • de Lera, Mercedes
  • Siegler, James
  • Requena, Manuel
Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Ictus; Mortalitat, Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Ictus; Mortalidad, Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Stroke; Mortality, Background and purpose Coronavirus disease 2019 (COVID-19) is associated with a small but clinically significant risk of stroke, the cause of which is frequently cryptogenic. In a large multinational cohort of consecutive COVID-19 patients with stroke, we evaluated clinical predictors of cryptogenic stroke, short-term functional outcomes and in-hospital mortality among patients according to stroke etiology. Methods We explored clinical characteristics and short-term outcomes of consecutively evaluated patients 18 years of age or older with acute ischemic stroke (AIS) and laboratory-confirmed COVID-19 from 31 hospitals in 4 countries (3/1/20–6/16/20). Results Of the 14.483 laboratory-confirmed patients with COVID-19, 156 (1.1%) were diagnosed with AIS. Sixty-one (39.4%) were female, 84 (67.2%) white, and 88 (61.5%) were between 60 and 79 years of age. The most frequently reported etiology of AIS was cryptogenic (55/129, 42.6%), which was associated with significantly higher white blood cell count, c-reactive protein, and D-dimer levels than non-cryptogenic AIS patients (p</=0.05 for all comparisons). In a multivariable backward stepwise regression model estimating the odds of in-hospital mortality, cryptogenic stroke mechanism was associated with a fivefold greater odds in-hospital mortality than strokes due to any other mechanism (adjusted OR 5.16, 95%CI 1.41–18.87, p = 0.01). In that model, older age (aOR 2.05 per decade, 95%CI 1.35–3.11, p < 0.01) and higher baseline NIHSS (aOR 1.12, 95%CI 1.02–1.21, p = 0.01) were also independently predictive of mortality. Conclusions Our findings suggest that cryptogenic stroke among COVID-19 patients carries a significant risk of early mortality., MER-A was funded by The Instituto de Salud Carlos III (JR19/00020), Spain.